OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
May 05, 2011
The IPEC is soliciting public comment about a draft plan for the independent certification of manufacturers and suppliers of pharmaceutical excipients.
May 02, 2011
Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.
Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
FDA, NIH and industry seek new strategies to spur drug development and promote access to therapies.
Many factors affect research results.
April 21, 2011
Axcan acquires Mpex Pharmaceuticals; Bend Research receives patent for improving bioavailability of low-solubility drugs; and More.
April 02, 2011
Courts and Congress seek to reshape policies and programs.
The contract-research industry in China is growing in leaps and bounds, and Big Pharma is leading the way.
PhRMA efforts of industry's R&D scientists.
Chemocatalytic and biocatalytic routes play an important role in improving the manufacture of intermediates and active pharmaceutical ingredients.